Shares of vaccine companies such as Moderna (MRNA), Pfizer (PFE) and BioNTech (BNTX), among others, are falling after a ...

MoneyShow presents top investment ideas for 2024 from leading advisors. Part 8 includes Lara Exploration, Imperial Oil, Avino ...

Shares of Google parent Alphabet slump after quarterly revenue misses analysts’ expectations, AMD’s data-center revenue ...

Pfizer CEO Albert Bourla said there are "opportunities that probably outweigh the risks" of the Trump administration's ...

Earnings season is in full swing in the pharma sector with major players sharing their latest results. On Tuesday (February 4 ...

In an interview on CNBC’s Mad Money, Dr. Albert Bourla said Pfizer (PFE) is focusing on business development to create shareholder value. “We ...

The company will present an open house on the project at 6 p.m. on Wednesday, Feb. 5 at the Livingston Township Hall.

The colon cancer BRAFF mutation study is one of the first to be initiated under the FDA’s Project FrontRunner.

The graphic shows Starbucks sales over the past year Although, this quarter may not be the one where the company sees the ...

It is reportedly planning to allow third-party app stores in the near future, if EU legislation forces the company to allow other app stores to compete with its own. We have collected data and ...

PF-07976016 is under clinical development by Pfizer and currently in Phase I for Obesity ... Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and ...

President-elect Donald Trump has said he wants to “reshore” U.S. companies, bringing more of their business activities — and their tax dollars — back home. The primary aim is to reduce ...